Centrally mediated disorders of gastrointestinal pain: An update with Rome V and a latin american perspective
DOI:
https://doi.org/10.22516/25007440.1636Keywords:
Abdominal pain, gut-brain axis, hyperalgesia, opioid-related disorders, migraine disordersAbstract
Background. DGBI are common clinical conditions in which digestive symptoms arise from altered motility, visceral hypersensitivity, mucosal and immune dysfunction, changes in the microbiota, and altered central processing. Rome V includes a category in which the contribution of the central nervous system predominates and in which pain, rather than luminal dysfunction, defines the illness.
Topic. Centrally mediated gastrointestinal pain disorders (CMGPD) comprise three entities: centrally mediated abdominal pain syndrome, adult abdominal migraine, and narcotic bowel syndrome. The most far-reaching change concerns the first. Rome IV required continuous pain unrelated to eating, defecation or menstruation; if it also fluctuated with meals, the patient was excluded and usually received the label of IBS. Rome V retains that profile and adds a category in which pain may be modified by physiological events while remaining continuous. The discriminator becomes the continuity of the pain, not its relationship with those events. Reciprocally, pain in IBS is now required not to be continuous. Criteria, epidemiology, mechanisms, diagnosis and treatment are reviewed.
Conclusions. CMGPD demand a shift in clinical reasoning: to stop searching for a luminal lesion and to treat an identifiable central mechanism. The supporting evidence is nonetheless heterogeneous and derives from small uncontrolled series, so recommendations should be presented as such. In Latin America, application further requires ruling out prevalent organic disease and adapting the plan to the availability of neuromodulators, psychogastroenterology and opioid withdrawal programmes.
Downloads
References
Drossman DA, Chang L, Tack J. Disorders of gut-brain interaction and the Rome V process. Gastroenterology. 2026;170(6):1083-1098. https://doi.org/10.1053/j.gastro.2026.02.014
Fukudo S, Aziz Q, Drossman DA, Van Oudenhove L, Farmer AD, Drewes AM, et al. Centrally mediated disorders of gastrointestinal pain. Gastroenterology. 2026;170(6):1283-1302. https://doi.org/10.1053/j.gastro.2025.12.038
Baethge C, Goldbeck-Wood S, Mertens S. SANRA—a scale for the quality assessment of narrative review articles. Res Integr Peer Rev. 2019;4:5. https://doi.org/10.1186/s41073-019-0064-8
Lembo A, Corsetti M, Aziz Q, Fukudo S. Clarification of “continuous” abdominal pain in Rome V diagnostic criteria of IBS and CAPS. Gastroenterology. 2026:S0016-5085(26)07065-4. https://doi.org/10.1053/j.gastro.2026.07.005
Corsetti M, Shin A, Lacy BE, Cash BD, Simrén M, Schmulson MJ, et al. Bowel disorders. Gastroenterology. 2026;170(6):1261-1282. https://doi.org/10.1053/j.gastro.2026.02.003
Staller K, Goodory VC, Khasawneh M, Black CJ, Ford AC. The Rome V criteria for the diagnosis of irritable bowel syndrome in secondary care: a diagnostic accuracy study. Lancet Gastroenterol Hepatol. 2026;11(9):812-820. https://doi.org/10.1016/S2468-1253(26)00118-4
Drossman DA, Tack J. Rome Foundation clinical diagnostic criteria for disorders of gut-brain interaction. Gastroenterology. 2022;162(3):675-679. https://doi.org/10.1053/j.gastro.2021.11.019
Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J, et al. Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study. Gastroenterology. 2021;160(1):99-114.e3. https://doi.org/10.1053/j.gastro.2020.04.014
Keefer L, Drossman DA, Guthrie E, Simrén M, Tillisch K, Olden K, et al. Centrally mediated disorders of gastrointestinal pain. Gastroenterology. 2016;150(6):1408-1419. https://doi.org/10.1053/j.gastro.2016.02.034
Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38(9):1569-1580. https://doi.org/10.1007/BF01303162
Greenwood-Van Meerveld B, Mawe GM, Beyder A, Brierley SM, Clarke G, Gulbransen BD, et al. Fundamentals of neurogastroenterology: basic science. Gastroenterology. 2026;170(6):1099-1113. https://doi.org/10.1053/j.gastro.2026.01.040
De Giorgio R, Boeckxstaens GE, Cryan JF, D’Amato M, Dinning PG, Hasler WL, et al. Fundamentals of neurogastroenterology: physiological aspects and clinical implications. Gastroenterology. 2026;170(6):1114-1132. https://doi.org/10.1053/j.gastro.2026.02.004
Elsenbruch S, Ballou S, Keefer L, Murphy TB, Van Oudenhove L, van Tilburg MAL, et al. Biopsychosocial aspects of adult and pediatric disorders of gut-brain interaction. Gastroenterology. 2026;170(6):1205-1223. https://doi.org/10.1053/j.gastro.2026.02.009
Ding K, Xiang H, Huo M, Xu K, Wang H. Clinical features of abdominal migraine: a systematic review and summary of data from 662 patients. Front Neurol. 2026;17:1760307. https://doi.org/10.3389/fneur.2026.1760307
Farmer AD, Gallagher J, Bruckner-Holt C, Aziz Q. Narcotic bowel syndrome. Lancet Gastroenterol Hepatol. 2017;2(5):361-368. https://doi.org/10.1016/S2468-1253(16)30217-5
Törnblom H, Carbone F, Hasler WL, Smout A, Suzuki H, Tack J, et al. Gastroduodenal disorders. Gastroenterology. 2026;170(6):1240-1260. https://doi.org/10.1053/j.gastro.2026.01.038
Drossman DA, Tack J, Ford AC, Szigethy E, Törnblom H, Van Oudenhove L. Neuromodulators for functional gastrointestinal disorders (disorders of gut-brain interaction): a Rome Foundation Working Team report. Gastroenterology. 2018;154(4):1140-1171.e1. https://doi.org/10.1053/j.gastro.2017.11.279
Medina-Rincón GJ, Gallo-Bernal S, Jiménez PA, Cruz-Saavedra L, Ramírez JD, Rodríguez MJ, et al. Molecular and clinical aspects of chronic manifestations in Chagas disease: a state-of-the-art review. Pathogens. 2021;10(11):1493. https://doi.org/10.3390/pathogens10111493
Organización Mundial de la Salud. Enfermedad de Chagas (tripanosomiasis americana) [Internet]. Ginebra: Organización Mundial de la Salud; 2026 [consultado el 5 de agosto de 2026]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/chagas-disease-(american-trypanosomiasis)
Herbella FAM, Malafaia O, Patti MG. New classification for esophageal motility disorders (Chicago Classification version 4.0©) and Chagas disease esophagopathy (achalasia). Arq Bras Cir Dig. 2022;34(4):e1624. https://doi.org/10.1590/0102-672020210002e1624
Wong RK, Fang X, Ghoshal UC, Kashyap PC, Mulak A, Lee YY, et al. Sociocultural aspects of the pathophysiology, clinical presentation, and management of disorders of gut-brain interaction. Gastroenterology. 2026;170(6):1190-1204. https://doi.org/10.1053/j.gastro.2026.02.006
Heitkemper MM, Larauche MH, Saito YA, Staller K, Harris LA, Walter S, et al. Patient experience, gender, age, race, and social determinants of health. Gastroenterology. 2026;170(6):1171-1189. https://doi.org/10.1053/j.gastro.2026.02.011
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista colombiana de Gastroenterología

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Aquellos autores/as que tengan publicaciones con esta revista, aceptan los términos siguientes:
Los autores/as ceden sus derechos de autor y garantizarán a la revista el derecho de primera publicación de su obra, el cuál estará simultáneamente sujeto a la Licencia de reconocimiento de Creative Commons que permite a terceros compartir la obra siempre que se indique su autor y su primera publicación en esta revista.
Los contenidos están protegidos bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.

| Article metrics | |
|---|---|
| Abstract views | 18 |
| Galley views | 11 |
| PDF Views | 11 |
| HTML views | 0 |
| Other views | 0 |














